Elizabeth Mansfield, FDA’s top official on personalized medicine, spoke to MedTech Insight about the agency’s thoughts behind two recently released next-generation sequencing draft guidances and where it plans to go next on the topic.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
